Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Carcangiu

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Nature Genetics|February 13, 1999
Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunctionM A St John, W Tao, X Fei, et al.
American Journal of Obstetrics and Gynecology|February 1, 1993
Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survivalF V Price, S K Chambers, J T Chambers, et al.
The American Journal of Pathology|March 18, 1999
Human ligands of the Notch receptorG E Gray, R S Mann, E Mitsiadis, et al.
International Journal of Cancer|June 19, 1993
Allelic loss in ovarian cancerT L Yang-Feng, H Han, K C Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2015
Management of breast cancer after Hodgkin's lymphoma and paediatric cancerM Terenziani, M Massimino, D Magazzù, et al.
Cancer|October 1, 1991
Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinomaA H Frank, P C Tseng, B G Haffty, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 16, 2017
Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective studyG Martelli, R Miceli, S Folli, et al.
American Journal of Clinical Pathology|April 13, 2000
Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptorE Diaz de Leon, M L Carcangiu, V G Prieto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2009
Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumoursA Perotti, C Sessa, A Mancuso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2008
Biology, prognosis and response to therapy of breast carcinomas according to HER2 scoreS Ménard, A Balsari, E Tagliabue, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Nature Genetics|February 13, 1999
Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunctionM A St John, W Tao, X Fei, et al.
American Journal of Obstetrics and Gynecology|February 1, 1993
Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survivalF V Price, S K Chambers, J T Chambers, et al.
The American Journal of Pathology|March 18, 1999
Human ligands of the Notch receptorG E Gray, R S Mann, E Mitsiadis, et al.
International Journal of Cancer|June 19, 1993
Allelic loss in ovarian cancerT L Yang-Feng, H Han, K C Chen, et al.
European Journal of Cancer (Oxford, England : 1990)|June 21, 2015
Management of breast cancer after Hodgkin's lymphoma and paediatric cancerM Terenziani, M Massimino, D Magazzù, et al.
Cancer|October 1, 1991
Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinomaA H Frank, P C Tseng, B G Haffty, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 16, 2017
Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective studyG Martelli, R Miceli, S Folli, et al.
American Journal of Clinical Pathology|April 13, 2000
Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptorE Diaz de Leon, M L Carcangiu, V G Prieto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2009
Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumoursA Perotti, C Sessa, A Mancuso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2008
Biology, prognosis and response to therapy of breast carcinomas according to HER2 scoreS Ménard, A Balsari, E Tagliabue, et al.
Pageof 11